BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 943 | Download: 1075
 |
Received |
|
2014-07-29 10:07 |
 |
Peer-Review Started |
|
2014-07-30 12:04 |
 |
To Make the First Decision |
|
2014-09-16 10:49 |
 |
Return for Revision |
|
2014-09-18 11:52 |
 |
Revised |
|
2014-10-01 20:34 |
 |
Second Decision |
|
2014-10-29 18:02 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-10-29 18:57 |
 |
Articles in Press |
|
2014-10-29 18:57 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-11-28 17:54 |
 |
Publish the Manuscript Online |
|
2014-12-12 11:14 |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
Telomerase activity: An attractive target for cancer therapeutics
|
Manuscript Source |
Invited Manuscript |
All Author List |
Lucia Picariello, Cecilia Grappone, Simone Polvani and Andrea Galli |
Funding Agency and Grant Number |
|
Corresponding Author |
Andrea Galli, MD, PhD, Professor, Gastroenterology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini n°6, 50139 Florence, Italy. andrea.galli@unifi.it |
Key Words |
Human telomerase reverse transcriptase; Immunotherapy; Suicide gene therapy; Acycloguanosyl 5’-thymidyltriphosphate; Telomerase inhibition |
Core Tip |
One of the hallmark of cancer is the replicative immortality of tumor cells guaranteed by telomerase activity that counteracts progressive telomere shortening during cellular replication: this makes telomerase a tumor marker and a target for anticancer drugs. In this review we summarize and update the most recent innovative studies and results on the different strategies that consider telomerase as a target for cancer therapy. In particular, we try to point out the advantages and the potentialities of some innovative approaches, compared to other, equally promising, but that need further investigations. |
Publish Date |
2014-12-12 11:14 |
Citation |
Picariello L, Grappone C, Polvani S, Galli A. Telomerase activity: An attractive target for cancer therapeutics. World J Pharmacol 2014; 3(4): 86-96 |
URL |
http://www.wjgnet.com/2220-3192/full/v3/i4/86.htm |
DOI |
http://dx.doi.org/10.5497/wjp.v3.i4.86 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345